Retec Healthcare Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 24-10-2024
- Paid Up Capital ₹ 1.20 M
as on 24-10-2024
- Company Age 13 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.52 Cr
as on 24-10-2024
- Revenue 55.47%
(FY 2023)
- Profit 51.52%
(FY 2023)
- Ebitda 440.69%
(FY 2023)
- Net Worth 19.63%
(FY 2023)
- Total Assets 31.75%
(FY 2023)
About Retec Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.20 M.
The company currently has active open charges totaling ₹1.52 Cr.
Anjani Pandey and Suvidha Pandey serve as directors at the Company.
- CIN/LLPIN
U24232DL2011PTC219855
- Company No.
219855
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 May 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Retec Healthcare Private Limited offer?
Retec Healthcare Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Protein Powder, Common Disease Medicines, Allopathic Cough Syrup, Multivitamin Syrup & Drops, Ayurvedic,Herbal Products & Medicine, Ayurvedic Herbal Syrups & Tonics, Ayurvedic & Herbal Extracts, Herbal Extracts, Ayurvedic Tablets.
Who are the key members and board of directors at Retec Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anjani Pandey  | Director | 25-May-2011 | Current |
| Suvidha Pandey | Director | 25-May-2011 | Current |
Financial Performance of Retec Healthcare.
Retec Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 55.47% increase. The company also saw a substantial improvement in profitability, with a 51.52% increase in profit. The company's net worth Soared by an impressive increase of 19.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Retec Healthcare?
In 2022, Retec Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Retec Formulations Private LimitedActive 26 years 10 monthsAnjani Pandey and Suvidha Pandey are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 14 Dec 2023 | ₹1.00 Cr | Open |
Syndicate Bank Creation Date: 30 Oct 2013 | ₹5.20 M | Open |
How Many Employees Work at Retec Healthcare?
Unlock and access historical data on people associated with Retec Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Retec Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Retec Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
